FK506 inhibition of histamine release and cytokine production by mast cells and basophils

International Journal of Immunopharmacology

Volumn 22, Issue 3, 2000, Pages 189-201

  Sengoku, T ^a   Kishi, S ^a   Sakuma, S ^a   Ohkubo, Y ^a   Goto, T ^a  

^a ASTELLAS PHARMA INC   (Japan)

Author keywords

Basophils; Cytokine production; FK506; Histamine release; Mast cells

Indexed keywords

ALCLOMETASONE DIPROPIONATE; BETAMETHASONE VALERATE; CROMOGLYCATE DISODIUM; HISTAMINE RELEASE INHIBITOR; INTERLEUKIN 4; STEROID; TACROLIMUS; TUMOR NECROSIS FACTOR ALPHA;

ALLERGY; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BASOPHIL; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG INHIBITION; DRUG MECHANISM; HISTAMINE RELEASE; IMMUNOPHARMACOLOGY; MALE; NONHUMAN; PERITONEUM MAST CELL; PRIORITY JOURNAL; RAT;

ANIMALS; BASOPHILS; CYTOKINES; HISTAMINE RELEASE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTERLEUKIN-4; MALE; MAST CELLS; RATS; RATS, INBRED BN; TACROLIMUS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033954276     PISSN: 01920561     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0192-0561(99)00076-4     Document Type: Article

References (40)

1. Del Prete G. Human Th1 and Th2 lymphocytes: their role in the pathophysiology of atopy. Allergy. 47:1992;450-455.
2. Busse W.W., Calhoun W.F., Sedgwick J.D. Mechanism of airway inflammation in asthma. Am. Rev. Respir. Dis. 147:1993;S20-S24.
3. Tonnel A.B., Gosset P., Molet S., Tillie-Leblond I., Jeannin P., Joseph M. Interactions between endothelial cells and effector cells in allergic inflammation. Ann. NY Acad. Sci. 796:1996;9-20.
4. Leung D.Y. Role of IgE in atopic dermatitis. Curr. Opin. Immunol. 5:1993;956-962.
5. Ackermann L., Harvima I.T. Mast cells of psoriatic and atopic dermatitis skin are positive for TNF-alpha and their degranulation is associated with expression of ICAM-1 in the epidermis. Arch. Dermatol. Res. 290:1998;353-359.
6. Grewe M., Gyufko K., Schöpf E., Krutmann J. Lesional expression of interferon-γ in atopic eczema. Lancet. 343:1994;25-26.
7. Grewe M., Walther S., Gyufko K., Czech W., Schöpf E., Krutmann J. Analysis of the cytokine pattern expressed in situ in inhalant allergen patch test reactions of atopic dermatitis patients. J. Invest. Dermatol. 105:1995;407-410.
8. Hamid Q., Boguniewicz M., Leung D.Y.M. Differential in situ cytokine gene expression in acute versus chronic atopic dermatitis. J. Clin. Invest. 94:1994;870-876.
9. + T cells. Immunol. Today. 12:1991;392-395.
10. Thepen T., Langeveld-Wildschut E.G., Bihari I.C., van Wichen D.F., van Reijsen F.C., et al. Biphasic response against aeroallergen in atopic dermatitis showing a switch from an initial TH2 response to a TH1 response in situ: An immunocytochemical study. J. Allergy Clin. Immunol. 97:1996;828-837.
11. Yamada N., Wakugawa M., Kuwata S., Yoshida T., Nakagawa H. Chronologic analysis of in situ cytokine expression in mite allergen-induced dermatitis in atopic subjects. J. Allergy Clin. Immunol. 96:1995;1069-1075.
12. Kino T., Hatanaka H., Hashimoto M., Nishiyama M., Goto T., et al. FK-506, a novel immunosuppressant isolated from a Streptomyces. I. Fermentation, isolation, and physico-chemical and biological characteristics. J. Antibiot. 40:1987;1249-1255.
13. Aoyama H., Tabata N., Tanaka M., Uesugi Y., Tagami H. Successful treatment of resistant facial lesions of atopic dermatitis with 0.1% FK506 ointment. Br. J. Dermatol. 133:1995;494-496.
14. Nakagawa H., Etoh T., Ishibashi Y., Higaki Y., Kawashima M., et al. Tacrolimus ointment for atopic dermatitis. Lancet. 344:1994;883.
15. Ruzicka T., Bieber T., Schöpf E., Rubins A., Dobozy A., et al. A short-term trial of tacrolimus ointment for atopic dermatitis. European Tacrolimus Multicenter Atopic Dermatitis Study Group. N. Engl. J. Med. 337:1997;816-821.
16. Andersson J., Nagy S., Groth C.G., Andersson U. Effects of FK506 and cyclosporin A on cytokine production studied in vitro at a single-cell level. Immunology. 75:1992;136-142.
17. Rao A. NF-Atp: a transcription factor required for the co-ordinate induction of several cytokine genes. Immunol. Today. 15:1994;274-281.
18. Schreiber S.L., Crabtree G.R. The mechanism of action of cyclosporin A and FK506. Immunol Today. 13:1992;136-142.
19. de Paulis A., Stellato C., Cirillo R., Ciccarelli A., Oriente A., Marone G. Anti-inflammatory effect of FK-506 on human skin mast cells. J. Invest. Dermatol. 99:1992;723-728.
20. Redrop A.C., Howard B.P., MacGlashan D.W. Jr, Kagey-Sobotka A., Lichtenstein L.M., Schroeder J.T. Differential regulation of IL-4 and IL-13 secretion by human basophils. Their relationship to histamine release in mixed leukocyte cultures. J. Immunol. 160:1998;1957-1964.
21. Enerbäck L., Svensson I. Isolation of rat peritoneal mast cells by centrifugation on density gradients of percoll. J. Immunol. Methods. 39:1980;135-145.
22. Columbo M., Galeone D., Guidi G., Kagey-Sobotka A., Lichtenstein L.M., et al. Modulation of mediator release from human basophils and pulmonary mast cells and macrophages by auranofin. Biochem. Pharmac. 39:1990;285-291.
23. Holgate S.T. The mast cell and its function in allergic disease. Clinical and Experimental Allergy. 21:1991;11-16.
24. Hom J.T., Estridge T. FK506 and rapamycin modulate the functional activities of human peripheral blood eosinophils. Clin. Immunol. Immunopathol. 68:1993;293-300.
25. Hossain M., Okubo Y., Sekiguchi M. Effects of various drugs (staurosporine, herbimycin A, ketotifen, theophylline, FK506 and cyclosporin A) on eosinophil viability. Jpn J. Allergol. 43:1994;711-717.
26. Burnett D., Adams D.H., Martin T.J.M., Liu Q., Grant R.A., et al. Inhibition by FK506 of formyl peptide-induced neutrophil activation and associated protein synthesis. Biochem. Pharmacol. 48:1994;1081-1088.
27. Kaye R.E., Fruman D.A., Bierer B.E., Albers M.W., Zydowsky L.D., et al. Effects of cyclosporin A and FK506 on Fcε receptor type I-initiated increases in cytokine mRNA in mouse bone marrow-derived progenitor mast cells: Resistance to FK506 is associated with a deficiency in FK506-binding protein FKBP12. Proc. Natl. Acad. Sci. 89:1992;8542-8546.
28. Hultsch T., Brand P., Lohmann S., Saloga J., Kincaid R.L., Knop J. Direct evidence that FK506 inhibition of Fcε RI-mediated exocytosis from RBL mast cells involves calcineurin. Arch. Dermatol. Res. 290:1998;258-263.
29. Carnuccio R., Di Rosa M., Ialenti A., Iuvone T., Sautebin L. Selective inhibition by vasocortin of histamine release induced by dextran and concanavalin-A from rat peritoneal cells. Br. J. Pharmac. 98:1989;32-34.
30. Church M.K., Young K.D. The characteristics of inhibition of histamine release from human lung fragments by sodium cromoglycate, salbutamol and chlorpromazine. Br. J. Pharmac. 78:1983;671-679.
31. Butchers P.R., Fullarton J.R., Skidmore I.F., Thompson L.E., Vardey C.J., Wheeldon A. A comparison of the anti-anaphylactic activities of salbutamol and disodium cromoglycate in the rat, the rat mast cell and in human lung tissue. Br. J. Pharmac. 67:1979;23-32.
32. Foreman J.C., Hallett M.B., Mongar J.L. Site of action of the antiallergic drugs cromoglycate and doxantrazole. Br. J. Pharmac. 59:1977;473P-474P.
33. Tanizaki Y., Ohtani J., Kimura I. Actions and cross-reactivity of antiallergic agents and a calcium channel antagonist on rat peritoneal mast cells. Difference in the action mechanisms and cross-reactivity among the agents. Agents Actions. 37:1992;8-15.
34. Briscoe D.M., Cotran R.S., Pober J.S. Effects of tumor necrosis factor, lipopolysaccharide, and IL-4 on the expression of vascular cell adhesion molecule-1 in vivo. J. Immunol. 149:1992;2954-2960.
35. Iademarco M.F., Barks J.L., Dean D.C. Regulation of vascular cell adhesion molecule-1 expression by IL-4 and TNFα in cultured endothelial cells. J. Clin. Invest. 95:1995;264-271.
36. 4 Integrin/VCAM-1 adhesion pathways. J. Immunol. 160:1998;5637-5645.
37. Del Prete G., Maggi E., Parronchi P., Chretien I., Tiri A., et al. IL-4 is an essential factor for the IgE synthesis induced in vitro by human T cell clones and their supernatants. J. Immunol. 140:1988;4193-4198.
38. Pene J., Rousset F., Briere F., Chretien I., Paliard X., et al. IgE production by normal human B cells induced by alloreactive T cell clones is mediated by IL-4 and suppressed by IFN-gamma. J. Immunol. 141:1988;1218-1224.
39. Vercelli D., Jabara H.H., Arai K., Geha R.S. Induction of human IgE synthesis requires interleukin 4 and T/B cell interactions involving the T cell receptor/CD3 complex and MHC class II antigens. J. Exp. Med. 169:1989;1295-1307.
40. Hide I., Toriu N., Nuibe T., Inoue A., Hide M., et al. Suppression of TNF-α secretion by azelastine in a rat mast (RBL-2H3) cell line. Evidence for differential regulation of TNF-α release, transcription, and degranulation. J. Immunol. 159:1997;2932-2940.